
Molecule: TRASTUZUMAB
ChEMBL ID: CHEMBL1201585
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 1998

Molecule: PERTUZUMAB
ChEMBL ID: CHEMBL2007641
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2012

Molecule: TRASTUZUMAB EMTANSINE
ChEMBL ID: CHEMBL1743082
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2013

Molecule: LAPATINIB DITOSYLATE
ChEMBL ID: CHEMBL1201179
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2007

Molecule: AFATINIB DIMALEATE
ChEMBL ID: CHEMBL2105712
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: AC-480
ChEMBL ID: CHEMBL1645462
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ALLITINIB
ChEMBL ID: CHEMBL1947204
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CP-724714
ChEMBL ID: CHEMBL483321
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CUDC-101
ChEMBL ID: CHEMBL598797
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: JNJ-26483327
ChEMBL ID: CHEMBL3109738
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MP-412
ChEMBL ID: CHEMBL5095024
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: TUCATINIB
ChEMBL ID: CHEMBL3989868
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: S-222611
ChEMBL ID: CHEMBL3545200
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MUBRITINIB
ChEMBL ID: CHEMBL1614707
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TAK-285
ChEMBL ID: CHEMBL1614725
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: HEMAY-022
ChEMBL ID: CHEMBL3545111
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PYROTINIB
ChEMBL ID: CHEMBL3647420
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AEE-788
ChEMBL ID: CHEMBL587723
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VARLITINIB
ChEMBL ID: CHEMBL2103842
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SAPITINIB
ChEMBL ID: CHEMBL2408045
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BMS-690514
ChEMBL ID: CHEMBL3545396
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MASOPROCOL
ChEMBL ID: CHEMBL313972
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: TESEVATINIB
ChEMBL ID: CHEMBL3544983
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CANERTINIB DIHYDROCHLORIDE
ChEMBL ID: CHEMBL545315
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NERATINIB
ChEMBL ID: CHEMBL180022
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: DACOMITINIB
ChEMBL ID: CHEMBL2105719
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: MARGETUXIMAB
ChEMBL ID: CHEMBL2364649
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2020

Molecule: GANCOTAMAB
ChEMBL ID: CHEMBL3833344
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ERTUMAXOMAB
ChEMBL ID: CHEMBL2108029
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MDX-210
ChEMBL ID: CHEMBL2109271
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: T-DM1
ChEMBL ID: CHEMBL2109399
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody drug conjugate

Molecule: DACOMITINIB ANHYDROUS
ChEMBL ID: CHEMBL2110732
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: NERATINIB MALEATE
ChEMBL ID: CHEMBL3989921
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: TRASTUZUMAB DERUXTECAN
ChEMBL ID: CHEMBL4297844
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2019

Molecule: TUXOBERTINIB
ChEMBL ID: CHEMBL4650279
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: TRASTUZUMAB DUOCARMAZINE
ChEMBL ID: CHEMBL4298178
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody drug conjugate

Molecule: KN-026
ChEMBL ID: CHEMBL4594568
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Unknown

Molecule: ZANIDATAMAB
ChEMBL ID: CHEMBL4650256
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: ANVATABART OPADOTIN
ChEMBL ID: CHEMBL4297892
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: MM-111
ChEMBL ID: CHEMBL4297556
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown

Molecule: ZENOCUTUZUMAB
ChEMBL ID: CHEMBL4298025
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: VANDETANIB
ChEMBL ID: CHEMBL24828
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2011

Molecule: POZIOTINIB
ChEMBL ID: CHEMBL3545154
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: KBP5209
ChEMBL ID: CHEMBL4650289
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Unknown

Molecule: TARLOXOTINIB
ChEMBL ID: CHEMBL4297661
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
